Healthcare -
Biotechnology - NASDAQ - US
$ 6.29
-4.26 %
$ 312 M
Market Cap
-1.26
P/E
RGNX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization RGNX - REGENXBIO Inc.
17.3 M
LAST VALUE
34.57%
2 YEAR CAGR
34.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR